17-hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 4, 2006, Pages 1011-1014

  Paonessa, Damian J ^a   Shields, Andrea D ^a   Howard, Bobby C ^a   Gotkin, Jennifer L ^a   Deering, Shad H ^a   Hoeldtke, Nathan J ^b   Napolitano, Peter G ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

Placenta; Placental vessels; Pregnancy; Progesterone

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN II; HYDROXYPROGESTERONE CAPROATE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FETOPLACENTAL UNIT; HUMAN; HUMAN TISSUE; PERFUSION PRESSURE; PLACENTA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANGIOTENSIN II; CYTOKINES; FEMALE; FETUS; HUMANS; HYDROXYPROGESTERONES; PLACENTA; PREGNANCY; VASOCONSTRICTION;

EID: 33748788570     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.06.041     Document Type: Article

References (12)

1. da Fonseca E.B., Bittar R.E., Carvalho M.H.B., and Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double blind study. Am J Obstet Gynecol 188 (2003) 419-424
2. Meis P.J., Kelbanoff M., Thom E., Dombrowski M.P., Sibai B., Moawad A.H., et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17-alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
3. Elovitz M., and Wang Z. Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol 190 (2004) 693-701
4. Shields A.D., Wright J., Paonessa D.J., Gotkin J., Howard B.C., Hoeldtke N.J., et al. Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model. Am J Obstet Gynecol 193 (2005) 1144-1148
5. Erny R., Pigne A., Prouvost C., Gamerre M., Malet C., Serment H., et al. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 154 (1986) 525-529
6. Murphy J.G., and Khalipl R.A. Decreased Ca (2+) during inhibition of coronary smooth muscle contraction by 17betaestradiol, progesterone, and testosterone. J Pharmacol Exp Ther 291 (1999) 44-52
7. Markenson G.R., Foley K., Maslow A.S., and Kopelman J.N. The effects of atrial natriuretic factor and angiotensin II on fetal-placental perfusion pressure in the ex vivo cotyledon model. Am J Obstet Gynecol 173 (1995) 1143-1147
8. Glance D.G., Elder M.G., Bloxam D.L., and Myatt L. The effects of the components of the rennin-angiotensin system on the isolated perfused human placental cotyledon. Am J Obstet Gynecol 149 (1984) 450-454
9. Napolitano P.G., Hoeldtke N.J., Moore K.H., Calhoun B.C., Christensen E.D., Markenson G.R., et al. The fetoplacental pressor effects of low-dose acetylsalicylic acid and angiotensin II in the ex vivo cotyledon model. Am J Obstet Gynecol 177 (1997) 1093-1096
10. Hoeldtke N.J., Wagner R.K., Calhoun B.C., and Hume R.F. Vasodilatory response of fetoplacental vasculature to adrenomedullin after constriction with the thromboxane sympathomimetic U46619. Am J Obstet Gynecol 183 (2000) 1573-1578
11. Li H.F., Zheng T.Z., Li W., Qu S.Y., and Zhang C.L. Effect of progesterone on the contractile response of isolated pulmonary artery in rabbits. Can J Physiol Pharmacol 79 (2001) 545-550
12. Glusa E., Graser T., Wagner S., and Oettel M. Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. Maturitas 28 (1997) 181-191